EUVIMEDEUVIMED entdecken
Open Access

Leptin as a key driver for organ fibrogenesis

Xue-Nan Sun iD, Shiuhwei Chen, Shangang Zhao iD, Jan-Bernd Funcke iD, Megan Virostek iD, Line Pedersen iD, Chao Li iD, Chanmin Joung iD, Qian Lin iD, Yan Li, Ayanna Cobb, May-Yun Wang und 10 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.ady7904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Xue-Nan Sun und 21 weiteren Autor:innen. Beteiligte Einrichtung: Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Leptin, Fibrosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptin, a hormone primarily secreted by adipocytes, regulates energy balance and systemic metabolism through its interaction with the leptin receptor (LEPR). Beyond these functions, leptin signaling has been implicated in the pathogenesis of tissue fibrosis. Here, we report the x-ray crystal structures of a leptin-neutralizing antibody (hLep3) in the unbound and leptin-bound states. The interaction of this antibody with leptin mimics the interaction of the LEPR with leptin, providing direct insights into the mechanism by which the antibody disrupts leptin signaling. We furthermore evaluate the therapeutic potential of neutralizing leptin with this antibody across distinct mouse models of fibrosis affecting the kidney, liver, lung, heart, and blood vessels. Leptin neutralization markedly inhibited fibrosis progression in all models. Mechanistically, suppression of leptin activity reduces pro-inflammatory and profibrotic processes, underscoring its therapeutic potential. These findings suggest that leptin signaling plays a vital role in tissue fibrosis and that treatment with a leptin-neutralizing antibody may be a promising therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinFibrosisAnimalsMiceReceptors, LeptinAntibodies, NeutralizingSignal TransductionHumansDisease Models, AnimalProtein Binding

Substanzen

LeptinReceptors, LeptinAntibodies, Neutralizing

Autor:innen und Institutionen

  • Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Sam and Ann Barshop Institute for Longevity and Aging Studies, Division of Endocrinology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

ORCID-Profile: Xue-Nan Sun, Shangang Zhao, Jan-Bernd Funcke, Megan Virostek, Line Pedersen, Chao Li, Chanmin Joung, Qian Lin, Kyounghee Min, Lisandro Maya-Ramos, Ningyan Zhang, Zhiqiang An, Diana R Tomchick, Da Young Oh, Philipp E Scherer

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Sun, X. N., Chen, S., Zhao, S., Funcke, J. B., Virostek, M., Pedersen, L., Li, C., Joung, C., Lin, Q., Li, Y., Cobb, A., Wang, M. Y., Min, K., Maya-Ramos, L., Degasperi, G., Liu, J., Zhang, N., An, Z., Tomchick, D. R., …, & Scherer, P. E. (2025). Leptin as a key driver for organ fibrogenesis. Science Advances. https://doi.org/10.1126/sciadv.ady7904

Vancouver

Sun XN, Chen S, Zhao S, Funcke JB, Virostek M, Pedersen L, et al. Leptin as a key driver for organ fibrogenesis. Science Advances. 2025. doi:10.1126/sciadv.ady7904

BibTeX
@article{Sun2025,
  author = {Sun, Xue-Nan and Chen, Shiuhwei and Zhao, Shangang and Funcke, Jan-Bernd and Virostek, Megan and Pedersen, Line and Li, Chao and Joung, Chanmin and Lin, Qian and Li, Yan and Cobb, Ayanna and Wang, May-Yun and Min, Kyounghee and Maya-Ramos, Lisandro and Degasperi, Giovanna and Liu, Junquan and Zhang, Ningyan and An, Zhiqiang and Tomchick, Diana R and Wynn, R Max and Oh, Da Young and Scherer, Philipp E},
  title = {Leptin as a key driver for organ fibrogenesis},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ady7904}
}
Kostenlos starten →